Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian James

Showing results (141-150 of 244) with videos related to

Pageof 25
Sort By:
British Journal of Clinical Pharmacology|March 26, 2008
Population pharmacokinetic/pharmacodynamic analysis of CCR5 receptor occupancy by maraviroc in healthy subjects and HIV-positive patientsMaria C Rosario, Philippe Jacqmin, Pat Dorr, et al.
Revista Da Escola De Enfermagem Da U S P|December 7, 2013
[Interprofessional education: training for healthcare professionals for teamwork focusing on users]Marina Peduzzi, Ian James Norman, Ana Claudia Camargo Gonçalves Germani, et al.
Nature Communications|May 29, 2024
Stochasticity, determinism, and contingency shape genome evolution of endosymbiotic bacteriaBret M Boyd, Ian James, Kevin P Johnson, et al.
Neuromuscular Disorders : NMD|December 7, 2007
Apolipoprotein epsilon alleles in sporadic inclusion body myositis: a reappraisalMerrilee Needham, Amanda Hooper, Ian James, et al.
Antiviral Therapy|May 29, 2008
Cytokine profiling in abacavir hypersensitivity patientsCoral-Ann M Almeida, Annalise M Martin, David Nolan, et al.
Genes and Immunity|November 18, 2016
HLA Class I and II alleles, heterozygosity and HLA-KIR interactions are associated with rates of genital HSV shedding and lesionsAmalia Magaret, Lichun Dong, Mina John, et al.
AIDS (London, England)|January 1, 2005
Predisposition to nevirapine hypersensitivity associated with HLA-DRB1*0101 and abrogated by low CD4 T-cell countsAnnalise M Martin, David Nolan, Ian James, et al.
AIDS (London, England)|May 9, 2009
Detection of low-frequency pretherapy chemokine (CXC motif) receptor 4 (CXCR4)-using HIV-1 with ultra-deep pyrosequencingJohn Archer, Michael S Braverman, Bruce E Taillon, et al.
Emergency Medicine Journal : EMJ|November 6, 2014
The Mersey Burns App: evolving a model of validationJamie Barnes, Annie Duffy, Nathan Hamnett, et al.
Blood Transfusion = Trasfusione Del Sangue|May 11, 2017
Strategies to identify candidates for D variant genotypingXunda Luo, Margaret A Keller, Ian James, et al.
Pageof 25

Showing results (141-150 of 244) with videos related to

Sort By:
Pageof 25
British Journal of Clinical Pharmacology|March 26, 2008
Population pharmacokinetic/pharmacodynamic analysis of CCR5 receptor occupancy by maraviroc in healthy subjects and HIV-positive patientsMaria C Rosario, Philippe Jacqmin, Pat Dorr, et al.
Revista Da Escola De Enfermagem Da U S P|December 7, 2013
[Interprofessional education: training for healthcare professionals for teamwork focusing on users]Marina Peduzzi, Ian James Norman, Ana Claudia Camargo Gonçalves Germani, et al.
Nature Communications|May 29, 2024
Stochasticity, determinism, and contingency shape genome evolution of endosymbiotic bacteriaBret M Boyd, Ian James, Kevin P Johnson, et al.
Neuromuscular Disorders : NMD|December 7, 2007
Apolipoprotein epsilon alleles in sporadic inclusion body myositis: a reappraisalMerrilee Needham, Amanda Hooper, Ian James, et al.
Antiviral Therapy|May 29, 2008
Cytokine profiling in abacavir hypersensitivity patientsCoral-Ann M Almeida, Annalise M Martin, David Nolan, et al.
Genes and Immunity|November 18, 2016
HLA Class I and II alleles, heterozygosity and HLA-KIR interactions are associated with rates of genital HSV shedding and lesionsAmalia Magaret, Lichun Dong, Mina John, et al.
AIDS (London, England)|January 1, 2005
Predisposition to nevirapine hypersensitivity associated with HLA-DRB1*0101 and abrogated by low CD4 T-cell countsAnnalise M Martin, David Nolan, Ian James, et al.
AIDS (London, England)|May 9, 2009
Detection of low-frequency pretherapy chemokine (CXC motif) receptor 4 (CXCR4)-using HIV-1 with ultra-deep pyrosequencingJohn Archer, Michael S Braverman, Bruce E Taillon, et al.
Emergency Medicine Journal : EMJ|November 6, 2014
The Mersey Burns App: evolving a model of validationJamie Barnes, Annie Duffy, Nathan Hamnett, et al.
Blood Transfusion = Trasfusione Del Sangue|May 11, 2017
Strategies to identify candidates for D variant genotypingXunda Luo, Margaret A Keller, Ian James, et al.
Pageof 25